HBV-related Decompensated Cirrhosis: Lamivudine vs Entecavir - Medscape News

Background Suppression of hepatitis B virus (HBV) DNA is more potent, and occurrence of resistant strain is rare with entecavir than lamivudine, but whether these merits result in a more favourable outcome in HBV-related decompensated cirrhosis ...

Aurobindo Bags USFDA Nod For Lamivudine & Zidovudine Tabs - Top News India

Aurobindo Pharma Limited has pocketed final authorization from the US Food and Drug Administration (FDA) to produce and sell lamivudine and zidovudine tabs USP 150/300mg (ANDA 202418). Hyderabad-based pharma major said that it is ready to launch the ...

Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - equitybulls.com

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch. Lamivudine & Zidovudine ...

Aurobindo Pharma gets US FDA approval for lamivudine & zidovudine tabs - pharmabiz.com

Aurobindo Pharma Limited, Hyderabad-based pharma major, has received final approval from the US FDA to manufacture and market lamivudine and zidovudine tablets USP 150/300mg (ANDA 202418) and is ready for launch. Lamivudine and zidovudine tablets USP 150 ...

Lupin Launches Generic Combivir Tablets - RTT News

(RTTNews) - Pharmaceutical company Lupin Ltd. announced that its subsidiary Lupin Pharmaceuticals inc. had obtained final approval from US FDA for its Lamivudine and Zidovudine tablets, 150mg/ 300mg. The Mumbai-based company said it already commenced ...

Aurobindo gets USFDA approval for two tablets - Business Standard

Hyderabad-based pharmaceutical company Aurobindo Pharma limited (APL) on Wednesday stated that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lamivudine and Zidovudine tablets. According to APL ...

South Africa exceeds 2007-11 treatment targets by 50% - Aidsmap

Crude estimates of numbers of public sector patients on treatment in each quarter were calculated according to lamivudine (3TC, Epivir) sales figures from Aspen Pharmacare, which supplied 80% of lamivudine to the public sector until recently. While they ...

Lupin report: New launches continue to fuel US growth - Stock Markets Review

Lupin has received approval and subsequently launched generic Lamivudine and Zidovudine Tablets (Brand name: Combivir; market size: US$275mn; Dosage: 150mg, 300mg; Indication: Antiretroviral) in the US. The company’s launch follows expiry of Teva’s six ...

Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019 - Yahoo Finance

504.3.6 Epivir-HBV (lamivudine) 524.3.7 Viread (tenovofir) 544.4 Key Takeaway 565 Hepatitis B Therapeutics - Pipeline Assessment 575.1 Overview 575.2 Strategic Pipeline Assessment 575.3 Hepatitis B Therapeutics - Pipeline Analysis by Clinical ...

FDA Advisory Committee Supports Approval of Gilead's Truvada for Reducing the Risk of Acquiring HIV - Phramalive.com

Truvada should not be co-administered with any other antiretroviral agents for HIV that contain emtricitabine or tenofovir disoproxil fumarate, nor should it be co-administered with products containing lamivudine. Do not administer with Hepsera.